Beclomethasone: Advanced Anti-Inflammatory Respiratory Relief

Cialis

Cialis

Price from 34.40 $
Product dosage: 10mg
Package (num)Per pillPriceBuy
10$3.44$34.40 (0%)🛒 Add to cart
20$2.36$68.80 $47.30 (31%)🛒 Add to cart
30$2.01$103.20 $60.20 (42%)🛒 Add to cart
60$1.58$206.40 $94.60 (54%)🛒 Add to cart
90$1.53$309.60 $137.60 (56%)🛒 Add to cart
120$1.36$412.80 $163.40 (60%)🛒 Add to cart
180$1.19$619.20 $215.00 (65%)🛒 Add to cart
270$1.05$928.80 $283.80 (69%)🛒 Add to cart
360
$0.96 Best per pill
$1238.40 $344.00 (72%)🛒 Add to cart
Product dosage: 2.5mg
Package (num)Per pillPriceBuy
30$1.29$38.70 (0%)🛒 Add to cart
60$1.15$77.40 $68.80 (11%)🛒 Add to cart
90$1.05$116.10 $94.60 (19%)🛒 Add to cart
120$1.00$154.80 $120.40 (22%)🛒 Add to cart
180$0.76$232.20 $137.60 (41%)🛒 Add to cart
270$0.67$348.30 $180.60 (48%)🛒 Add to cart
360
$0.59 Best per pill
$464.40 $210.70 (55%)🛒 Add to cart
Product dosage: 20mg
Package (num)Per pillPriceBuy
10$3.87$38.70 (0%)🛒 Add to cart
20$2.79$77.40 $55.90 (28%)🛒 Add to cart
30$2.44$116.10 $73.10 (37%)🛒 Add to cart
60$2.15$232.20 $129.00 (44%)🛒 Add to cart
90$1.91$348.30 $172.00 (51%)🛒 Add to cart
120$1.79$464.40 $215.00 (54%)🛒 Add to cart
180$1.43$696.60 $258.00 (63%)🛒 Add to cart
270$1.21$1044.90 $326.80 (69%)🛒 Add to cart
360
$1.12 Best per pill
$1393.20 $404.20 (71%)🛒 Add to cart
Product dosage: 5mg
Package (num)Per pillPriceBuy
20$1.94$38.70 (0%)🛒 Add to cart
30$1.72$58.05 $51.60 (11%)🛒 Add to cart
60$1.29$116.10 $77.40 (33%)🛒 Add to cart
90$1.24$174.15 $111.80 (36%)🛒 Add to cart
120$1.07$232.20 $129.00 (44%)🛒 Add to cart
180$0.96$348.30 $172.00 (51%)🛒 Add to cart
270$0.83$522.45 $223.60 (57%)🛒 Add to cart
360
$0.75 Best per pill
$696.60 $270.90 (61%)🛒 Add to cart
Synonyms

Similar products

Beclomethasone represents a cornerstone in modern respiratory therapeutics as a potent inhaled corticosteroid. This medication delivers targeted anti-inflammatory action directly to the airways, making it a first-line treatment for managing chronic respiratory conditions. Its sophisticated delivery mechanism ensures maximum therapeutic effect with minimized systemic exposure, offering patients sustained symptom control and improved quality of life. Medical professionals consistently prescribe beclomethasone for its established efficacy profile and favorable safety record when used as directed.

Features

  • Potent glucocorticoid receptor agonist with high local anti-inflammatory activity
  • Metered-dose inhaler or dry powder formulation for precise dosing
  • Microfine particle technology for optimal lung deposition
  • Chemical stability across various temperature ranges
  • Minimal systemic bioavailability due to first-pass metabolism
  • Rapid onset of action within 24-72 hours of initiation
  • Compatible with most spacer devices for improved delivery

Benefits

  • Significantly reduces airway inflammation and mucosal edema
  • Decreases frequency and severity of asthma exacerbations
  • Improves lung function measurements (FEV1, PEFR)
  • Reduces reliance on rescue bronchodilators
  • Allows for better disease control and symptom management
  • Enhances overall quality of life through improved respiratory function
  • May prevent airway remodeling with long-term use

Common use

Beclomethasone is primarily indicated for the prophylactic management of persistent asthma in patients aged 5 years and older. It is also commonly prescribed for maintenance treatment of chronic obstructive pulmonary disease (COPD) in patients with a history of recurrent exacerbations. Off-label uses include management of eosinophilic bronchitis and certain cases of allergic rhinitis when nasal formulations are specifically employed. The medication is not intended for relief of acute bronchospasm but rather for long-term control of underlying inflammatory processes.

Dosage and direction

Dosage must be individualized based on disease severity and patient response. For asthma management in adults: initial dose typically ranges from 40-160 mcg twice daily, with maximum recommended dose of 320 mcg twice daily. For children 5-11 years: initial dose of 40 mcg twice daily, maximum 80 mcg twice daily. Administration technique is critical—patients should shake the inhaler well before use, exhale completely, position inhaler correctly, actuate while breathing in slowly and deeply, and hold breath for 10 seconds. Rinsing the mouth after each use is essential to prevent oral candidiasis. Dosage adjustments should be made gradually under medical supervision.

Precautions

Patients should be monitored for any signs of systemic corticosteroid effects during long-term therapy, particularly with higher doses. Regular assessment of height in pediatric patients is recommended due to potential growth suppression. Caution is advised in patients with active or quiescent tuberculosis infections, untreated fungal, bacterial, or viral infections, or ocular herpes simplex. Pulmonary function should be periodically monitored. Patients should not discontinue therapy abruptly as adrenal insufficiency may occur. Immunocompromised individuals may require additional monitoring.

Contraindications

Beclomethasone is contraindicated in patients with known hypersensitivity to beclomethasone dipropionate or any component of the formulation. Primary treatment of status asthmaticus or other acute episodes where intensive measures are required represents another contraindication. The medication should not be used for non-asthmatic bronchitis or as the sole treatment for significantly deteriorating asthma. Patients with untreated systemic infections or active tuberculosis should not initiate therapy until appropriate treatment has been established.

Possible side effects

Common local adverse effects include oropharyngeal candidiasis (5-10%), hoarseness/dysphonia (5-8%), and throat irritation (3-5%). Systemic effects are rare at recommended doses but may include adrenal suppression, reduced bone mineral density, cataracts, glaucoma, and growth retardation in children. Other reported effects include headache (2-4%), cough immediately after inhalation (3-6%), and paradoxical bronchospasm (<1%). Most local side effects can be minimized with proper inhaler technique and mouth rinsing.

Drug interaction

Beclomethasone may interact with strong CYP3A4 inhibitors (ketoconazole, ritonavir) potentially increasing systemic corticosteroid exposure. Concurrent use with other corticosteroids (oral, nasal, or inhaled) may increase the risk of hypothalamic-pituitary-adrenal axis suppression. Diuretics may enhance hypokalemia effects. Live vaccines should be administered with caution in patients receiving immunosuppressive doses. No clinically significant interactions have been reported with short-acting bronchodilators.

Missed dose

If a dose is missed, it should be taken as soon as remembered unless it is nearly time for the next scheduled dose. In that case, patients should skip the missed dose and resume their regular dosing schedule. Doubling of doses is not recommended. Patients should maintain regular dosing intervals to ensure consistent therapeutic levels in the airways. If multiple doses are missed, medical consultation is advised as symptom control may be compromised.

Overdose

Acute overdose is unlikely to produce life-threatening symptoms due to the medication’s local action and limited systemic bioavailability. However, chronic excessive dosing may lead to systemic corticosteroid effects including hypercorticism and adrenal suppression. Management involves discontinuation of the medication and supportive care. Adrenal function testing may be warranted. There is no specific antidote; treatment should be symptomatic and supportive. Medical attention should be sought for suspected overdose.

Storage

Store at controlled room temperature (20-25°C/68-77°F) with excursions permitted between 15-30°C (59-86°F). Keep the canister away from direct sunlight and heat sources. Do not puncture or incinerate the container, even after it appears empty. Keep the cap tightly closed when not in use. Store in a dry place away from moisture. Do not freeze. Keep out of reach of children. Discard the inhaler after the labeled number of actuations has been used, even if it continues to emit spray.

Disclaimer

This information is provided for educational purposes only and does not constitute medical advice. Individual patient needs may vary, and healthcare professionals should be consulted for specific medical recommendations. Dosage and administration should be determined by a qualified physician based on individual patient assessment. The manufacturer’s prescribing information should be consulted for complete details regarding use, warnings, and precautions.

Reviews

Clinical studies demonstrate that beclomethasone provides effective asthma control in approximately 70-80% of patients when used appropriately. Pulmonary specialists report consistent improvement in symptom scores and reduction in exacerbation frequency. Patients note improved exercise tolerance and reduced nighttime symptoms. The medication receives generally positive evaluations for its reliability and established safety profile, though some users report difficulty with proper inhaler technique requiring additional training. Long-term studies confirm maintained efficacy with continuous use.